Wow
Someone hasnt done their DD...
This is far from the usual overpaid Aussie Biotech appointment that you are implying.... Taking on all of the risk of improved share performance to get any remuneration, unlike the issues he has raised in his posts on this issue..
and this is a bit old now but
http://www.business.gov.au/grants-a...iving-Dangerously---Dr-Chris-Behrenbruch.aspx
